Synthesis and inhibitory activity of thymidine analogues targeting Mycobacterium tuberculosis thymidine monophosphate kinase
Sara Van Poecke, Hélène Munier-Lehmann, Olivier Helynck, Matheus Froeyen, Serge Van Calenbergh
Index: Bioorg. Med. Chem. 19(24) , 7603-1, (2011)
Full Text: HTML
Abstract
We report on Mycobacterium tuberculosis thymidine monophosphate kinase (TMPKmt) inhibitory activities of a series of new 3'- and 5'-modified thymidine analogues including α- and β-derivatives. In addition, several analogues were synthesized in which the 4-oxygen was replaced by a more lipophilic sulfur atom to probe the influence of this modification on TMPKmt inhibitory activity. Several compounds showed an inhibitory potency in the low micromolar range, with the 5'-arylthiourea 4-thio-α-thymidine analogue being the most active one (K(i)=0.17 μM). This compound was capable of inhibiting mycobacteria growth at a concentration of 25 μg/mL.Copyright © 2011 Elsevier Ltd. All rights reserved.
Related Compounds
Related Articles:
Synthesis and biological evaluation of sorafenib- and regorafenib-like sEH inhibitors.
2013-07-01
[Bioorg. Med. Chem. Lett. 23(13) , 3732-7, (2013)]
A novel p21 attenuator which is structurally related to sorafenib.
2013-03-01
[Cancer Biol. Ther. 14(3) , 278-85, (2013)]
A highly efficient methodology for 5-methyl-3-aryl-2-thiooxazolidin-4-ones using lithium perchlorate in DIPEA mediated synthesis. Khatik GL, et al.
[J. Heterocycl. Chem. 47(3) , 734, (2010)]
Extraction and determination of the Mitins sulcofuron and flucofuron from environmental river water. áM Hancock P.
[Analyst 123(8) , 1669-74, (1998)]